Jamil H. Khan, MD

As a clinically focused neonatologist, Dr. Khan has always been interested in ways to improve care of the babies in the NICU, and after their NICU stay. Surfactant was still an experimental drug when he arrived at CHKD in 1988. Dr. Khan championed CHKD's participation in a "late Phase 3" trial that allowed CHKD to treat over 100 babies who otherwise could not have received this life-saving medicine. Dr. Khan also assumed the role of the director of the neonatal follow-up clinic. Dr. Khan has been drawn to looking at the complex issues of how doctors and nurses and parents make difficult decisions in the NICU, and in the delivery room, especially with extremely premature babies. He also serves on the CHKD bioethics advisory committee.